Today's Daily Dose brings you news about Apellis Pharma's pipeline progress; licensing agreement between Knight Therapeutics and TherapeuticsMD; anticipated milestones of Progenics Pharma, and discontinuation of Shire's phase II NASH trial.
from RTT - Biotech https://ift.tt/2OAbj0y
via IFTTT
No comments:
Post a Comment